NHS approves app for cancer related fatigue
Fatigue is one of the most common side effects of cancer and its treatment, with 70-80% of patients affected.
Read More
Tag: Untire
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
